Transaktionen anzeigen
Private Equity | Gesundheitswesen

AmberStone Group has acquired a stake in Vītola Klīnika and has developed New Hanza Med in Riga

AmberStone Group AS has acquired a 49% stake in Vītola Klīnika and invested in its expansion and relocation to new premises, leading to the creation of New Hanza Med — a modern, multidisciplinary medical and surgical center in the New Hanza district of Riga, Latvia.

Located at Mihaila Tāla iela 1, the new facility brings together specialists from diverse healthcare fields under one roof, providing a full spectrum of services from preventive care to complex surgical procedures. With this project, the group continues to strengthen its position in the healthcare sector, aiming to bring world-class medical standards to Latvia.

AmberStone Group is a Latvia-based investment holding company founded in 2013, specializing in private equity-style investments across sectors including healthcare, hospitality, agriculture, construction, wood processing and renewable energy. The group has extensive experience and a strong track record in developing medical facilities, notably ORTO Clinic.

Vītola Klīnika offers a comprehensive range of gynecological, diagnostic and surgical services delivered by experienced specialists. Patients benefit from advanced technology, effective treatment methods and a personalized approach, ensuring a seamless continuum of care from initial consultation and diagnostics through surgery and post-operative recovery.

Oaklins’ team in Latvia acted as the exclusive buy-side advisor to AmberStone Group, supporting the investment thesis, identifying potential acquisition targets, facilitating introductions and negotiating deal terms.

DIENSTLEISTUNG
PARTEIEN

Sprechen Sie mit dem Deal Team

Evelīna Valtere

Associate Director
Riga, Lettland
Oaklins Baltics

Transaktionen

Valmiermuižas Alus has been acquired by Cēsu Alus
Private Equity | Lebensmittel- und Getränkeindustrie

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Mehr erfahren
Die Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland
Gesundheitswesen

Die Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland

Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.

Mehr erfahren
Armira has signed an agreement to acquire a majority stake in Viabus
Private Equity | Handel

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Mehr erfahren